Okyo Pharma Limited NPV (OKYO) RNS Announcements

Add to Alert list
Date Time Source Announcement
09 Feb 2024 12:00 PM
GNW
OKYO Pharma Receives FDA Approval of IND for ...
31 Jan 2024 12:00 PM
GNW
OKYO Pharma Announces Distinguished Ophthalmo...
08 Jan 2024 12:00 PM
GNW
OKYO Pharma Announces OK-101 Successfully Ach...
05 Jan 2024 02:30 PM
GNW
OKYO Pharma to Present at the Biotech Showcas...
04 Dec 2023 12:00 PM
GNW
OKYO Pharma Announces Last Patient Enrolled i...
31 Oct 2023 11:00 AM
GNW
OKYO Pharma Announces $5.84 Million Cash Rais...
09 Oct 2023 12:00 PM
GNW
OKYO Pharma Announces Filing of an Investigat...
05 Oct 2023 12:00 PM
GNW
OKYO Pharma Announces Positive Safety Data Pr...
15 Sep 2023 12:00 PM
GNW
OKYO Pharma Announces Closing of $4.0 Million...
14 Sep 2023 02:15 PM
GNW
OKYO Pharma Announces Pricing of $4.0 Million...
14 Sep 2023 01:45 PM
GNW
OKYO Pharma Limited Announces Withdrawal of P...
13 Sep 2023 09:05 PM
GNW
OKYO Pharma Announces Public Offering of Ordi...
08 Sep 2023 12:00 PM
GNW
OKYO Pharma Completes Enrollment in Phase 2 C...
30 Aug 2023 12:00 PM
GNW
OKYO Pharma Achieves 90% Enrollment in 240-Pa...
29 Aug 2023 12:00 PM
GNW
OKYO Pharma Limited Regains Compliance with N...
15 Aug 2023 02:00 PM
GNW
OKYO Pharma Limited Reports Annual Results fo...
31 Jul 2023 07:18 AM
GNW
OKYO Pharma Limited Announces Withdrawal of P...
28 Jul 2023 10:25 PM
GNW
OKYO Pharma Announces Proposed Public Offerin...
28 Jul 2023 12:01 PM
GNW
OKYO Pharma Plans to Initiate Phase 2 Trial o...
27 Jul 2023 04:30 PM
GNW
OKYO Pharma Announces Appointment of William ...
06 Jun 2023 02:30 PM
GNW
OKYO Pharma Announces Randomized Segment Now ...
22 May 2023 08:15 AM
RNS
London Stock Exchange Delisting
19 May 2023 08:00 AM
RNS
ADS Program collapse
15 May 2023 07:00 AM
RNS
Change of Record Time and Last Day of Dealings
11 May 2023 12:00 PM
RNS
Webull Corporate Communications Service Platform
11 May 2023 07:00 AM
RNS
Change of Delisting Date to 22 May 2023
03 May 2023 01:00 PM
RNS
Result of Meeting
03 May 2023 07:00 AM
RNS
Presentation on OK-101 at ASCRS
02 May 2023 07:00 AM
RNS
First-Patient First-Visit for Phase 2 Trial
25 Apr 2023 07:00 AM
RNS
Activation of First Clinical Trial Site in the U.S
25 Apr 2023 07:00 AM
RNS
Activation of First Clinical Trial Site in the U.S
25 Apr 2023 07:00 AM
OKYO Pharma Announces Activation of First Clini...
05 Apr 2023 07:00 AM
RNS
NOTICE OF GENERAL MEETING AND CIRCULAR PUBLICATION
05 Apr 2023 07:00 AM
Notice of General Meeting and Publication of Ci...
04 Apr 2023 07:00 AM
RNS
Notice Of Intention To Delist From The LSE
04 Apr 2023 07:00 AM
Notice of Intention to Delist From The London S...
30 Mar 2023 07:01 AM
OKYO Pharma Today Announces Director Acquires S...
30 Mar 2023 07:00 AM
RNS
Director Acquires Shares
29 Mar 2023 07:00 AM
RNS
Director acquires shares
29 Mar 2023 07:00 AM
OKYO Pharma Today Announces Director Acquires S...
24 Mar 2023 07:00 AM
RNS
Director/PDMR Shareholding
24 Mar 2023 07:00 AM
OKYO Pharma Announces PDMR Dealing
16 Mar 2023 07:01 AM
RNS
Listing of Trial on the ClinicalTrials.gov Website
16 Mar 2023 07:01 AM
OKYO Pharma Announces Phase 2 Trial of OK-101 D...
16 Mar 2023 07:00 AM
RNS
Closing of Global Private Placement
15 Mar 2023 07:01 AM
RNS
Director/PDMR Dealings
14 Mar 2023 07:00 AM
RNS
Issue of Equity
14 Mar 2023 07:00 AM
OKYO Pharma Limited announces U.S.$5.74 million...
13 Mar 2023 03:16 PM
RNS
CEO Interview
06 Mar 2023 02:00 PM
RNS
Price Monitoring Extension
UK 100

Latest directors dealings